Skip to main content

Immediate treatment versus active-surveillance in very-low-risk prostate cancer: the role of hospital-related factors.

Jansen
H.
Research
Netherlands Comprehensive Cancer Organisation
Utrecht
The Netherlands
Show all authors
van Oort
I.
Radboud Institute for Health Sciences, Department of Urology
Radboud university medical center
Nijmegen
The Netherlands
van Andel
G.
Department of Urology
Onze Lieve Vrouwe Gasthuis
Amsterdam
The Netherlands
Wijsman
B.P.
Department of Urology
Elisabeth-TweeSteden Hospital
Tilburg
The Netherlands
Pos
F.
Department of Radiotherapy
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Amsterdam
The Netherlands
Hulshof
M.C.C.M.
Department of Radiotherapy
Academic Medical Center
Amsterdam
The Netherlands
Hulsbergen-van de Kaa
C.A.
Radboud Institute for Health Sciences, Department of Pathology
Radboud university medical center
Nijmegen
The Netherlands
van Leenders
G.J.L.H.
Department of Pathology
Erasmus Medical Center Rotterdam
Rotterdam
The Netherlands
Fütterer
J.J.
Radboud Institute for Health Sciences, Department of Radiology and Nuclear Medicine
Radboud university medical center
Nijmegen
The Netherlands
Somford
D.M.
Department of Urology
Canisius-Wilhelmina Hospital
Nijmegen
The Netherlands
Busstra
M.B.
Department of Urology
Erasmus Medical Center Rotterdam
Rotterdam
The Netherlands
van Moorselaar
R.J.A.
Department of Urology
VU University Medical Center
Amsterdam
The Netherlands
Kiemeney
L.A.
Radboud Institute for Health Sciences, Department for Health Evidence
Radboud university medical center
Nijmegen
The Netherlands
Aben
K.K.H.
Research
Netherlands Comprehensive Cancer Organisation
Utrecht
The Netherlands

Tabs

Speciality: 
Urology
Keywords: 
low-risk, active surveillance, hospital-related factors